Insider Transactions in Q4 2021 at Ionis Pharmaceuticals Inc (IONS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 15
2021
|
Michael R Hayden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,777
+11.11%
|
-
|
|
Oct 15
2021
|
Peter N Reikes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,777
+11.11%
|
-
|
|
Oct 15
2021
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
145
-1.98%
|
$5,075
$35.1 P/Share
|
|
Oct 15
2021
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
417
+5.39%
|
-
|